Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion type Assertion NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_head.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion description "[Foxa1 protein expression was always observed in human prostate carcinomas, regardless of Gleason grade score, while Foxa2 was only detected in neuroendocrine small cell carcinomas and in some high Gleason score adenocarcinomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_provenance.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion evidence source_evidence_literature NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_provenance.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion SIO_000772 16001449 NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_provenance.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion wasDerivedFrom befree-2016 NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_provenance.
- NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_assertion wasGeneratedBy ECO_0000203 NP502838.RAfNcdDF2rWSSbDJYYJGb6mEoLkxOeQZBfzAMnJCcomqY130_provenance.